Water for Injection vs. Purified Water: Understanding the Differences

Water for Injection vs. Purified Water

Table of Contents

Introduction

Since pure Water is an integral part of pharmaceutical processes, the water quality cannot be compromised. The violation of regulatory compliances leads to product recalls, which not only affect the company’s finances but may also cause severe harm to the reputation of the company. The Water for Injection and Purifies Water has its application purpose; they are not interchangeable. 

The lack of knowledge about their specific applications, standards and production processes can significantly impact product quality and compliance. This blog highlights the key differences between WFI and PW and answers a few FAQs. Keep reading to learn more.

What is Water for Injection (WFI)?

Water for Injection (WFI) is pristine water used to manufacture parenteral drugs. Since parenteral medications are administered directly into the body via muscle, vein, or skin, bypassing the digestive system, the water used needs to be ultra-pure to ensure patient safety. Water is treated using distillation or reverse osmosis processes to meet the stringent standards set by pharmacopeial guidelines like the United States Pharmacopeia (USP) and the European Pharmacopoeia (EP).

WFI is free from endotoxins, microorganisms, and inorganic contaminants. It is often sterilised and must be maintained under sterile conditions until used. Other than Injectable drugs, WFI is also used in processes where sterility is paramount. 

TSA’s state-of-the-art technology delivers water for injections far superior to global pharmacopoeia standards. The multi-column distillation plant is highly efficient, having flow rates ranging from 80 LPH to 5000 LPH. The system is pre-passivated to ensure high flexibility with a production capacity of up to 80% without any additional modifications to the plant. 

The plant features a sleek mechanical construction using SS 316L, with all contact parts electropolished to a finish of less than 0.4 RA microns. Additionally, the joints are orbitally welded and inspected with a video boroscope. It offers quick start-up with enhanced performances and maximum energy savings while in compliance with USFDA 21 CFR part 11 and GAMP 5

What is Purified Water (PW)?

Purified Water (PW) is also high-quality water like WFI. It is used extensively in manufacturing, pharma, and biotech. However, its purity requirements are slightly less stringent than those of WFI. Deionisation, reverse osmosis or a combination of the water purification processes are employed to produce Purified Water. 

The purified water is not sterile and is used to manufacture non-parenteral products like tablets, capsules, topical formulations, and clean equipment and containers. 

TSA offers an advanced closed-loop recirculation system for sustainable operations to align your business with sustainable development goals. The water treatment solutions are available in various models with flow rates ranging from 200 LPH (0.2m³/hr) to 20,000 LPH (20m³/hr).

As the water is recycled, the system saves water and energy. The Purified Water generation system has full or partial heat sanitising and incorporates softening, reverse osmosis and continuous electrode-ionization. All systems are skid mounted and comply with the validation of USFDA 21 CFR part 11 and GAMP 5.

Water for Injection vs Purified Water

In the pharma, biopharma and biotech industries, Water for injection and Purified water are used for different purposes. Therefore, knowing the fundamental differences helps us to make the right choice. Here’s a table of differentiation between them: 

CriteriaWater For InjectionPurified Water
Quality StandardsThe WFI water must meet USP, EP, and JP standards for endotoxin, which is <0.25EU/mL and the microbial limits <10 CFU/100mL. PW must meet USP and EP standards to ensure chemical purity and conductivity. The microbial limits are less stringent than WFI. 
RegulationsCompliance with current Good Manufacturing Practices and stringent bacterial endotoxin and sterility tests are mandatory.Regular checks for microbial contamination and chemical purity are required. Endotoxin testing is not required.  
ProductionProcesses like distillation double-pass reverse osmosis followed by ultrafiltration are employed to purify water. The production equipment must be sanitised and validated regularly. Processes like reverse osmosis, deionisation or a combination of such filtration methods are employed for water purification. 
Storage and DistributionIt must be stored in a way that prevents any microbial growth. It requires a heated storage and recirculation system to preserve the quality.The storage system must prevent contamination and is usually sanitised periodically. However, it requires a different level of control than for the WFI system.
Validation WFI water must undergo rigorous validation procedures besides regular endotoxin and microbial testing, system validation and ongoing monitoring to ensure it complies with strict standards. The PW validation procedures primarily focus on ensuring chemical purity and the appropriate microbial limits. The method is less rigorous than WFI validation.
MonitoringThe water purification system needs to be continuously or frequently monitored to check the integrity of the system and its sanitation status. Regular monitoring of the water purification system is required but with less stringent requirements, unlike WFI. 
Product QualityDirectly impacts the sterility and safety of injectable products, making it critical to ensure patient safety.Although PW is not directly involved in producing sterile drugs, it is necessary to ensure non-parenteral products’ chemical and microbial quality.  
Cost-effectivenessWFI is more expensive than PW because of the rigorous purification processes.PW is less costly than WFI.
ApplicationsUsed to formulate drugs, reconstitute products, and final rinse for equipment and components in aseptic processes requiring the highest purity.They are typically used to formulate non-sterile product formulations, rinse containers, clean non-critical equipment, and general laboratory use. 

TSA’s Water Purification Systems

We offer high-quality water purification systems

As we understand the critical role that high-purity water plays in pharmaceutical and biotech manufacturing, we render rigorous quality control processes to ensure that our Water for Injection and Purified Water meets and exceeds industry standards worldwide. By partnering with us, you can expect:

  • Reliable Quality: We ensure consistent delivery of high-quality water to meet your needs. 
  • Expertise and Support: Our team of multidisciplinary experts is available around the clock to provide guidance and support to ensure your processes run smoothly.
  • Customised Solutions: We understand customers need customisations. We provide tailored solutions to meet the unique needs of your production processes.

Invest in the purity of your products by choosing TSA as your trusted supplier for Water for Injection and Purified Water. 

Conclusion

As we wrap up this blog, it must be clear that adherence to pharmacopeial standards is non-negotiable. Using the wrong type of water can violate regulatory standards, leading to costly delays and potential product recalls. Since the purity of water directly affects the quality of the product, WFI is suitable to minimise any risk of introducing harmful contaminants into the injectable drugs, thus safeguarding the patient’s health. 

For a manufacturing business to sustain itself, consistently delivering high-quality products is quintessential as it builds trust with healthcare providers, enhancing your company’s reputation in the market. 

Make an informed choice with us and elevate the quality of your pharmaceutical and biotech products. To explore advanced water purification systems, reach out to us at TSA.

FAQs

1. How do recent FDA regulations impact the production and use of WFI and PW?

Recent FDA actions have underscored the importance of stringent quality controls and regular monitoring to prevent contamination and ensure the safety of pharmaceutical products.

2. What advancements in water purification technology are being adopted in the industry?

Advancements include improved filtration methods, automated monitoring systems, and enhanced sanitisation technologies, ensuring higher reliability and compliance with regulatory standards.

3. What contingency plans should be in place in case of a water quality failure?

Establish clear protocols for immediate response to water quality failures, including isolation of affected batches, detailed investigation procedures, and contingency supply plans to prevent production halts.

Share this post:

For 20 years, we’ve been the go-to problem-solvers for high-purity and injectable process applications in the pharma and biopharma industry. We are relentless about continuous process improvement and upskilling, elevating ourselves and our technology so you can get the job done more efficiently with cost optimisations. Use the form below to schedule a call back from our team.

Name(Required)
This field is for validation purposes and should be left unchanged.

Hetal Panchal is the Vice President in Operations department of TSA Process Equipments (A Thermax Group Company) since 1 s t October 2012.

Holding a qualification in Production Engineering and 28 years of industry experience, he specializes in designing advanced equipment for the pharmaceutical sector. His expertise lies in optimizing production lines, improving efficiency, and ensuring compliance with regulatory standards.
Focused on innovation, he has developed systems that enhances productivity, minimizes downtime, and maintains product quality. Staying current with technological trends, they contribute to ongoing improvements in the industry.
His extensive experience has helped identify opportunities for innovation, streamlining operations and reducing costs. Through his specialized knowledge, more efficient manufacturing processes and higher-quality outputs in pharmaceutical production are delivered.

B.C. Mahesh is the Chairperson of TSA Process Equipment Pvt. Ltd. since Feb 2024.

B.C. Mahesh became a member of the Executive Council in August 2013. He is responsible for the Industrial Product Business (IPB), which consists of Process Heating, Absorption Cooling & Heating Solutions, Water and Waste Solutions, Air Pollution Control, Steam Engineering, Channel Business Group, International Business Group, and Enterprise Sales businesses.
As part of IPB, he also oversees the following wholly-owned subsidiaries
of Thermax – Danstoker, PT Thermax International Indonesia and Rifox.Mahesh joined Thermax as a graduate trainee in 1988 and handled the Materials function for various businesses, including global sourcing, till 1996.
He moved to the Power division(P&ES) and grew to the position of Sales Head and subsequently Head of Projects. He took over as the Head of the SBU for Medium Power Plants in 2009 and finally as Head of Power business in 2012.
Mahesh has worked with Thermax for over 30 years in many functions such as manufacturing, supply chain, sales and marketing, and project management, and has played a significant role in the strategy, expansion and diversification of the Power business.Mahesh completed his Mechanical Engineering from the Visvesvaraya Regional College of Engineering, Nagpur in 1988.

Vishal Mehra is the Director of TSA Process Equipment Pvt. Ltd. since Feb 2024.

Mr. Vishal Mehra is currently serving as the Strategic Business Unit Head for Water & Waste Solutions (WWS) at Thermax Limited. Additionally, he holds a directorial position at TSA Process Equipment, which is known for its expertise in ultra-pure and high-purity water technologies and was recently acquired by Thermax.With over 22 years of experience in the industry, Mr. Mehra’s professional focus includes water management solutions, advanced technology development, and business strategy.
His areas of interest encompass cutting-edge technology, growth strategies, organizational effectiveness, and development.
Mr. Mehra is well qualified in business management and strategy transformation, having completed the Senior Executive Program in Business Management and Strategy Transformation from London Business School. This advanced education supports his extensive experience and expertise in the field.

Sandeep Deshpande has been the Director of TSA Process Equipments Pvt. Ltd. since February 2024.

Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Sandeep is a qualified Cost Accountant Company Secretary, and holds a diploma in IFRS and an advanced diploma in financial management from XLRI. He has extensive experience in financial operations, including financial planning, MIS, budgeting, controlling, audits, and cash flow management. His expertise also spans financial reporting, consolidation, mergers and acquisitions, due diligence, business restructuring, and implementing Internal Financial Control (IFC) and Enterprise Risk Management (ERM). Additionally, Sandeep has hands-on experience with Oracle systems, automation, digitization, and business analytics. He is passionate about driving good governance, improving financial reporting, and leveraging automation and digitization to enhance business analytics.

Rajiv Parikh is the COO of TSA Process Equipments (A Thermax Group Company) since April 2024.

Rajiv is a highly accomplished professional with extensive experience in the pharmaceutical and FMCG sectors, specializing in high-purity and process vessels. He played a key role in establishing TSA Process Equipments Pvt. Ltd., driving its growth and success. His deep technical expertise, combined with a strong understanding of client needs, has enabled him to deliver innovative solutions to complex industry challenges.

Throughout his career, Rajiv has excelled in leadership and sales, consistently launching cutting-edge products that have positively impacted the market. His ability to build lasting client relationships and offer tailored solutions has earned him a reputation as a trusted industry leader.

With a background in Mechanical Engineering, Rajiv blends technical proficiency with strategic vision. His contributions have shaped industry standards and positioned him as a key influencer in the pharmaceutical and FMCG sectors.

Apurva Shah is the CEO of TSA Process Equipments (A Thermax Group Company) since April 2024.

With a career spanning over 24 years, Apurva is the visionary CEO of TSA Process Equipments, where he has led the company to new heights in the High Purity & process equipment industry. A graduate in Mechanical Engineering from Mumbai University, followed by an MBA in Business Management from NMIMS, He brings a strong technical foundation combined with a sharp strategic mindset.

His expertise lies in formulating and executing strategies that drive growth and operational efficiency. Over the years, he has cultivated a deep understanding of market dynamics, positioning TSA Process Equipments for continued success in a competitive landscape.

Outside of his professional pursuits. He is an avid reader, with a particular interest in fiction novels, which fuel his creativity and broaden his perspective.